Phasebio Pharmaceuticals Inc raised $34,000,000 on , from Cormorant Asset Management, Fletcher ....

Get alertedif Phasebio Pharmaceuticals Inc gets funded!
Investors:, , , , , , ,
United States
Key people:Craig A. Rosen (Executive Chairman & CSO)
Susan Arnold (Vice President of Preclinical and Assay Development)
Guy Fish (Board Member, Director)
Lynne Georgopoulos (Senior Vice President of Clinical Development)
M. James Barrett (Board Member)
Asish K. Xavier (Board Member)
Justin Klein (Board Member, Director)
Jonathan Mow (Chief Business Office, Director, Executive Officer)
Christopher Prior (CEO, Director, Executive_Officer)
Joel Sussman (CFO, Executive Officer, Executive_Officer)
Data sources: - PhaseBio raises another $34 million for ?orphan diseases? - Pharmacy Choice - Pharmaceutical News - PhaseBio raises $34 million for its longer-lasting blood drugs [The Philadelphia Inquirer] - September 6, 2018 - Malvern-based PhaseBio Secures $34 Million in Series D Financing - MyChesCo - PhaseBio Secures $34 Million in Series D Financing - PhaseBio - PhaseBio, Developing PAH Therapy, Secures $34M to Advance Therapies - PhaseBio Secures $34 Million in Series D Financing | BioSpace
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!